Huvepharma® is a fast-growing global pharmaceutical company with a focus on developing, manufacturing and marketing of human and animal health products. These pillars are the basis of our company name, Huvepharma: HUman and VEterinary PHARMAceuticals. We place equal emphasis on the production and marketing of products for animals and for humans. The company also manufactures and markets enzymes for food, feed and industrial applications. Huvepharma is a privately-owned company, headquartered in Sofia, Bulgaria.

Huvepharma's manufacturing subsidiary, Biovet, is headquartered in Peshtera, Bulgaria with three production units in the country and two facilities in the USA. Its modern fermentation plants provide a high capacity for production of major molecules including purification and downstream processing. The production subsidiary has also extensive R&D, quality assurance and packaged goods warehouses. Our expertise lies in building a close partnership with our customers focusing on their overall requirements for pharmaceuticals and feed additives. In each of our locations, Huvepharma employs highly skilled individuals with extensive experience in the animal health industry and with knowledge of local markets and customers.

Huvepharma has representative offices and subsidiaries in Bulgaria, Belgium, Poland, China, Taiwan, Thailand, USA, Russia, India and Brazil, Turkey. This sales and marketing network facilitates Huvepharma products and services to reach its customers worldwide.

Huvepharma® is built on strong foundations and a long-lasting reputation of the business that make up our group.

The company is now benefiting from the synergies between its management and marketing know-how and the development strategy, coupled with more than half a century of expertise and tradition in human and animal health products via the companies we have acquired in the past: Biovet, Zelin, Balkanpharma-Razgrad and Intervet's Feed Additives business.

As a result of internal development and external acquisition, Huvepharma has transformed into a global pharmaceutical production and marketing company.